Stockreport

Pacira Announces the Presentation of 104-Week Safety and Efficacy Data Following Local Administration of PCRX-201 for Moderate to Severe Osteoarthritis of the Knee

Pacira BioSciences, Inc.  (PCRX) 
Last pacira biosciences, inc. earnings: 2/20 08:00 am Check Earnings Report
US:NASDAQ Investor Relations: investor.pacira.com
PDF -- Poster to be presented at ACR Convergence annual meeting -- TAMPA, Fla., Sept. 26, 2024 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (NASDAQ: PCRX), the industry l [Read more]